References

Key articles

Christian MD, Poutanen SM, Loutfy MR, et al. Severe acute respiratory syndrome. Clin Infect Dis. 2004;38:1420-1427.Full text external link opens in a new windowAbstract external link opens in a new window

Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-1772.Abstract external link opens in a new window

Mahony JB, Richardson S. Molecular diagnosis of severe acute respiratory syndrome: the state of the art. J Mol Diagn. 2005;7:551-559.Abstract external link opens in a new window

Peiris JS, Yuen KY, Osterhaus AD, et al. The severe acute respiratory syndrome. N Engl J Med. 2003;349:2431-2441.Abstract external link opens in a new window

Fowler RA, Lapinsky SE, Hallet D, et al. Critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290:367-373.Full text external link opens in a new windowAbstract external link opens in a new window

Reference articles

1. Christian MD, Poutanen SM, Loutfy MR, et al. Severe acute respiratory syndrome. Clin Infect Dis. 2004;38:1420-1427.Full text external link opens in a new windowAbstract external link opens in a new window

2. World Health Organization: global alert and response (GAR). Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. December 2003 [internet publication].Full text external link opens in a new window

3. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319-1325.Abstract external link opens in a new window

4. Hui DS, Chan MC, Wu AK, et al. Severe acute respiratory syndrome (SARS): epidemiology and clinical features. Postgrad Med J. 2004 Jul;80(945):373-81.Full text external link opens in a new windowAbstract external link opens in a new window

5. Kuiken T, Fouchier RA, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet. 2003;362:263-270.Abstract external link opens in a new window

6. Guan Y, Zheng BJ, He YQ, et al. Isolation and characterization of viruses related to SARS coronavirus from animals in southern China. Science. 2003;302:276-278.Full text external link opens in a new windowAbstract external link opens in a new window

7. Cheng VC, Lau SK, Woo PC, et al. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007;20:660-694.Full text external link opens in a new windowAbstract external link opens in a new window

8. Anderson LJ, Tong S. Update on SARS research and other possibly zoonotic coronaviruses. Int J Antimicrob Agents. 2010;36(suppl 1):S21-S25.Abstract external link opens in a new window

9. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450-454.Abstract external link opens in a new window

10. World Health Organization. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). May 2003 [internet publication].Full text external link opens in a new window

11. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-1772.Abstract external link opens in a new window

12. Parashar UD, Anderson LJ. Severe acute respiratory syndrome: review and lessons of the 2003 outbreak. Int J Epidemiol. 2004;33:628-634.Full text external link opens in a new windowAbstract external link opens in a new window

13. Lipsitch M, Cohen T, Cooper B, et al. Transmission dynamics and control of severe acute respiratory syndrome. Science. 2003;300:1966-1970.Full text external link opens in a new windowAbstract external link opens in a new window

14. Shen Z, Ning F, Zhou W, et al. Superspreading SARS events, Beijing, 2003. Emerg Infect Dis. 2004;10:256-260.Abstract external link opens in a new window

15. Varia M, Wilson S, Sarwal S, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ. 2003;169:285-292.Full text external link opens in a new windowAbstract external link opens in a new window

16. Tsang KW, Ooi GC, Ho PL. Diagnosis and pharmacotherapy of severe acute respiratory syndrome: what have we learnt? Eur Respir J. 2004;24:1025-1032.Abstract external link opens in a new window

17. Nicholls JM, Poon LL, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet. 2003;361:1773-1778.Abstract external link opens in a new window

18. Gu J, Korteweg C. Pathology and pathogenesis of severe acute respiratory syndrome. Am J Pathol. 2007;170:1136-1147.Full text external link opens in a new windowAbstract external link opens in a new window

19. Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1977-1985.Full text external link opens in a new windowAbstract external link opens in a new window

20. Lin M, Tseng HK, Trejaut JA, et al. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet. 2003;4:9.Full text external link opens in a new windowAbstract external link opens in a new window

21. Centers for Disease Control and Prevention. Public health guidance for community-level preparedness and response to severe acute respiratory syndrome (SARS) version 2. Supplement B: SARS surveillance. Appendix B1: revised CSTE SARS surveillance case definition. May 2005 [internet publication].Full text external link opens in a new window

22. Scales DC, Green K, Chan AK, et al. Illness in intensive care staff after brief exposure to severe acute respiratory syndrome. Emerg Infect Dis. 2003;9:1205-1210.Abstract external link opens in a new window

23. Lau JT, Lau M, Kim JH, et al. Probable secondary infections in households of SARS patients in Hong Kong. Emerg Infect Dis. 2004;10:235-243.Abstract external link opens in a new window

24. Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986-1994.Full text external link opens in a new windowAbstract external link opens in a new window

25. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801-2809.Abstract external link opens in a new window

26. Wong KT, Antonio GE, Hui DS, et al. Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. Radiology. 2003;228:401-406.Full text external link opens in a new windowAbstract external link opens in a new window

27. Chu CM, Leung YY, Hui JY, et al. Spontaneous pneumomediastinum in patients with severe acute respiratory syndrome. Eur Respir J. 2004;23:802-804.Full text external link opens in a new windowAbstract external link opens in a new window

28. Grinblat L, Shulman H, Glickman A, et al. Severe acute respiratory syndrome: radiographic review of 40 probable cases in Toronto, Canada. Radiology. 2003;228:802-809.Full text external link opens in a new windowAbstract external link opens in a new window

29. Centers for Disease Control and Prevention. Severe acute respiratory syndrome (SARS). February 2013 [internet publication].Full text external link opens in a new window

30. Mahony JB, Petrich A, Louie L, et al. Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse-transcription-PCR assays for detection of severe acute respiratory syndrome coronavirus. J Clin Microbiol. 2004;42:1471-1476.Full text external link opens in a new windowAbstract external link opens in a new window

31. Mahony JB, Richardson S. Molecular diagnosis of severe acute respiratory syndrome: the state of the art. J Mol Diagn. 2005;7:551-559.Abstract external link opens in a new window

32. Grant PR, Garson JA, Teddar RS, et al. Detection of SARS coronavirus in plasma by real-time RT-PCR. N Engl J Med. 2003;349:2468-2469.Abstract external link opens in a new window

33. Richardson SE, Tellier R, Mahony J. The laboratory diagnosis of severe acute respiratory syndrome: emerging laboratory tests for an emerging pathogen. Clin Biochem Rev. 2004;25:133-142.Abstract external link opens in a new window

34. Kammila S, Das D, Bhatnagar PK, et al. A rapid point of care immunoswab assay for SARS-CoV detection. J Virol Methods. 2008;152:77-84.Full text external link opens in a new windowAbstract external link opens in a new window

35. Das D, Kammila S, Suresh MR. Development, characterization, and application of monoclonal antibodies against severe acute respiratory syndrome coronavirus nucleocapsid protein. Clin Vaccine Immunol. 2010;17:2033-2036.Full text external link opens in a new windowAbstract external link opens in a new window

36. Peiris JS, Yuen KY, Osterhaus AD, et al. The severe acute respiratory syndrome. N Engl J Med. 2003;349:2431-2441.Abstract external link opens in a new window

37. Hon KL, Leung CW, Cheng WT, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet. 2003;361:1701-1703.Abstract external link opens in a new window

38. Lau KK, Yu WC, Chu CM, et al. Possible central nervous system infection by SARS coronavirus. Emerg Infect Dis. 2004;10:342-344.Abstract external link opens in a new window

39. Fisher DA, Lim TK, Lim YT, et al. Atypical presentations of SARS. Lancet. 2003;361:1740.Abstract external link opens in a new window

40. Centers for Disease Control and Prevention. Severe acute respiratory syndrome (SARS). February 2013. http://www.cdc.gov (last accessed 6 July 2016).Full text external link opens in a new window

41. Hui DS, Memish ZA, Zumla A. Severe acute respiratory syndrome vs. the Middle East respiratory syndrome. Curr Opin Pulm Med. 2014;20:233-241.Abstract external link opens in a new window

42. World Health Organization: global alert and response (GAR). Alert, verification and public health management of SARS in the post-outbreak period. August 2003 [internet publication].Full text external link opens in a new window

43. World Health Organization: global alert and response (GAR). Severe acute respiratory syndrome (SARS): WHO guidelines/recommendations/descriptions. 2004 [internet publication].Full text external link opens in a new window

44. Wong SS, Yuen KY. The management of coronavirus infections with particular reference to SARS. J Antimicrob Chemother. 2008;62:437-441.Full text external link opens in a new windowAbstract external link opens in a new window

45. Donnelly CA, Ghani AC, Leung GM, et al. Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003;361:1761-1766.Abstract external link opens in a new window

46. Wang YH, Lin AS, Chao TY, et al. A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan. Intensive Care Med. 2004;30:1228-1231.Abstract external link opens in a new window

47. Fowler RA, Lapinsky SE, Hallet D, et al. Critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290:367-373.Full text external link opens in a new windowAbstract external link opens in a new window

48. Esquinas AM, Egbert Pravinkumar S, Scala R, et al; International NIV Network. Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review. Eur Respir Rev. 2014;23:427-438.Full text external link opens in a new windowAbstract external link opens in a new window

49. Levy MM, Baylor MS, Bernard GR, et al. Clinical issues and research in respiratory failure from severe acute respiratory syndrome. Am J Respir Crit Care Med. 2005;171:518-526.Abstract external link opens in a new window

50. Mandell LA, Wunderink RG, Anzueto A, et al; Infectious Diseases Society of America, American Thoracic Society. Consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72.Full text external link opens in a new windowAbstract external link opens in a new window

51. Chu CM, Cheng VC, Hung IF, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004;59:252-256.Full text external link opens in a new windowAbstract external link opens in a new window

52. Chen RC, Tang XP, Tan SY, et al. Treatment of severe acute respiratory syndrome with glucosteroids: the Guangzhou experience. Chest. 2006;129:1441-1452.Full text external link opens in a new windowAbstract external link opens in a new window

53. Ho JC, Wu AY, Lam B, et al. Pentaglobin in steroid-resistant severe acute respiratory syndrome. Int J Tuberc Lung Dis. 2004;8:1173-1179.Abstract external link opens in a new window

54. Ströher U, DiCaro A, Li Y, et al. Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha. J Infect Dis. 2004;189:1164-1167.Full text external link opens in a new windowAbstract external link opens in a new window

55. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med. 2006;3:e343.Full text external link opens in a new windowAbstract external link opens in a new window

56. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, et al; Convalescent Plasma Study Group. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis. 2015;211:80-90.Full text external link opens in a new windowAbstract external link opens in a new window

57. Maunder RG, Lancee WJ, Balderson KE, et al. Long-term psychological and occupational effects of providing hospital healthcare during SARS outbreak. Emerg Infect Dis. 2006;12:1924-1932.Full text external link opens in a new windowAbstract external link opens in a new window

58. Yeung KS, Yamanaka GA, Meanwell NA. Severe acute respiratory syndrome coronavirus entry into host cells: opportunities for therapeutic intervention. Med Res Rev. 2006;26:414-433.Abstract external link opens in a new window

59. Chen L, Liu P, Gao H, et al. Inhalation of nitric oxide in the treatment of severe acute respiratory syndrome: a rescue trial in Beijing. Clin Infect Dis. 2004;39:1531-1535.Abstract external link opens in a new window

60. Coughlin M, Lou G, Martinez O, et al. Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse. Virology. 2007;361:93-102.Abstract external link opens in a new window

61. Liu X, Zhang M, He L, et al. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database Syst Rev. 2012;(10):CD004882.Full text external link opens in a new windowAbstract external link opens in a new window

62. Wu CJ, Jan JT, Chen CM, et al. Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamide. Antimicrob Agents Chemother. 2004;48:2693-2696.Full text external link opens in a new windowAbstract external link opens in a new window

63. Wen CC, Kuo YH, Jan JT, et al. Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem. 2007;50:4087-4095.Abstract external link opens in a new window

64. Chang Z, Babiuk LA, Hu J. Therapeutic and prophylactic potential of small interfering RNAs against severe acute respiratory syndrome: progress to date. BioDrugs. 2007;21:9-15.Abstract external link opens in a new window

65. Yap Y, Zhang X, Andonov A, et al. Structural analysis of inhibition mechanisms of aurintricarboxylic acid on SARS-CoV polymerase and other proteins. Comput Biol Chem. 2005;29:212-219.Abstract external link opens in a new window

66. Barnard DL, Day CW, Bailey K, et al. Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice. Antivir Chem Chemother. 2006;17:275-284.Abstract external link opens in a new window

67. Balzarini J, Keyaerts E, Vijgen L, et al. Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics. Antiviral Res. 2006;72:20-33.Abstract external link opens in a new window

68. Lin CW, Tsai FJ, Tsai CH, et al. Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. Antiviral Res. 2005;68:36-42.Abstract external link opens in a new window

69. Barnard DL, Hubbard VD, Burton J, et al. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine. Antivir Chem Chemother. 2004;15:15-22.Abstract external link opens in a new window

70. Keyaerts E, Vijgen L, Pannecouque C, et al. Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle. Antiviral Res. 2007;75:179-187.Abstract external link opens in a new window

71. Fiore C, Eisenhut M, Krausse R, et al. Antiviral effects of Glycyrrhiza species. Phytother Res. 2008;22:141-148.Abstract external link opens in a new window

72. Vincent MJ, Bergeron E, Benjannet S, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69.Full text external link opens in a new windowAbstract external link opens in a new window

73. Tang F, Quan Y, Xin ZT, et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. J Immunol. 2011;186:7264-7268.Abstract external link opens in a new window

74. Li J, Ulitzky L, Silberstein E, et al. Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates. Viral Immunol. 2013;26:126-132.Full text external link opens in a new windowAbstract external link opens in a new window

75. Chen WH, Du L, Chag SM, et al. Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate. Hum Vaccin Immunother. 2014;10:648-658.Abstract external link opens in a new window

76. The College of Physicians and Surgeons of Ontario. Infection prevention and control for clinical office practice. April 2015 [internet publication].Full text external link opens in a new window

77. Fiore AE, Fry A, Shay D, et al; Centers for Disease Control and Prevention (CDC). Antiviral agents for the treatment and chemoprophylaxis of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60:1-24.Full text external link opens in a new windowAbstract external link opens in a new window

78. Tsui PT, Kwok ML, Yuen H, et al. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis. 2003;9:1064-1069.Abstract external link opens in a new window

79. Chan JW, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 2003;58;686-689.Abstract external link opens in a new window

80. Wong RS, Wu A, To KF, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ. 2003;326:1358-1362.Full text external link opens in a new windowAbstract external link opens in a new window

81. Lew TW, Kwek TK, Tai D, et al. Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome. JAMA. 2003;290:374-380.Abstract external link opens in a new window

82. Chan KS, Zheng JP, Mok YW, et al. SARS: prognosis, outcome and sequelae. Respirology. 2003;8:S36-S40.Abstract external link opens in a new window

83. Chiu WK, Cheung PC, Ng KL, et al. Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong. Pediatr Crit Care Med. 2003;4:279-283.Abstract external link opens in a new window

84. Bitnun A, Allen U, Heurter H, et al. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics. 2003;112:e261.Full text external link opens in a new windowAbstract external link opens in a new window

85. Tansey CM, Louie M, Loeb M, et al. One-year outcomes and health care utilization in survivors of severe acute respiratory syndrome. Arch Intern Med. 2007;167:1312-1320.Full text external link opens in a new windowAbstract external link opens in a new window

86. Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol. 2011;11:37.Full text external link opens in a new windowAbstract external link opens in a new window

87. Xie L, Liu Y, Xiao Y, et al. Follow-up study on pulmonary function and lung radiographic changes in rehabilitating severe acute respiratory syndrome patients after discharge. Chest. 2005;127:2119-2124.Full text external link opens in a new windowAbstract external link opens in a new window

88. Tsai LK, Hsieh ST, Chang YC. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwan. 2005;14:113-119.Abstract external link opens in a new window

89. Wong SF, Chow KM, Leung TN, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191:292-297.Abstract external link opens in a new window

90. Griffith JF, Antonio GE, Kumta SM, et al. Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids. Radiology. 2005;235:168-175.Full text external link opens in a new windowAbstract external link opens in a new window

91. World Health Organization. WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS): updated recommendations. October 2004 [internet publication].Full text external link opens in a new window

92. Centers for Disease Control and Prevention. Severe acute respiratory syndrome (SARS): infection control. October 2012 [internet publication].Full text external link opens in a new window

93. Lai TS, Yu WC. The lessons of SARS in Hong Kong. Clin Med. 2010;10:50-53.Abstract external link opens in a new window

94. Yen MY, Lin YE, Lee CH, et al. Taiwan's traffic control bundle and the elimination of nosocomial severe acute respiratory syndrome among healthcare workers. J Hosp Infect. 2011;77:332-337.Abstract external link opens in a new window

95. Naylor CD, Chantler C, Griffiths S. Learning from SARS in Hong Kong and Toronto. JAMA. 2004;291:2483-2487.Abstract external link opens in a new window

96. Smith JD, MacDougall CC, Johnstone J, et al. Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis. CMAJ. 2016;188:567-574.Full text external link opens in a new windowAbstract external link opens in a new window

97. Jefferson T, Del Mar C, Dooley L, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2011;(7):CD006207.Full text external link opens in a new windowAbstract external link opens in a new window

98. Chen WQ, Ling WH, Lu CY, et al. Which preventive measures might protect health care workers from SARS? BMC Public Health. 2009;9:81.Full text external link opens in a new windowAbstract external link opens in a new window

99. Maxwell C, McGeer A, Young Tai KF, et al. Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS). J Obstet Gynaecol Can. 2009;31:358-372.Full text external link opens in a new windowAbstract external link opens in a new window

Use of this content is subject to our disclaimer